Regencell Bioscience Holdings Limited
RGC
$13.36
$1.028.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.90M | 4.90M | 7.96M | 4.80M | 4.80M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.80K | 5.80K | 152.80K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 5.03M | 5.03M |
| Total Current Assets | 4.90M | 4.90M | 8.11M | 9.83M | 9.83M |
|
|
|||||
| Total Current Assets | 4.90M | 4.90M | 8.11M | 9.83M | 9.83M |
| Net Property, Plant & Equipment | 759.80K | 759.80K | 226.50K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 93.00K | 93.00K | 97.70K | 642.40K | 642.40K |
| Total Assets | 5.76M | 5.76M | 8.44M | 10.48M | 10.48M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 348.40K | 348.40K | 125.30K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 312.80K | 312.80K | 59.80K | -- | -- |
| Total Finance Division Other Current Liabilities | 2.50K | 2.50K | 8.40K | -- | -- |
| Total Other Current Liabilities | 2.50K | 2.50K | 8.40K | -- | -- |
| Total Current Liabilities | 663.70K | 663.70K | 193.60K | -- | -- |
|
|
|||||
| Total Current Liabilities | 663.70K | 663.70K | 193.60K | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 231.60K | 231.60K | 25.90K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 312.60K | 312.60K |
| Total Liabilities | 895.30K | 895.30K | 219.50K | 312.60K | 312.60K |
|
|
|||||
| Common Stock & APIC | 30.13M | 30.13M | 29.88M | 10.16M | 10.16M |
| Retained Earnings | -25.20M | -25.20M | -21.62M | -- | -- |
| Treasury Stock & Other | -64.80K | -64.80K | -45.80K | -- | -- |
| Total Common Equity | 4.86M | 4.86M | 8.22M | 10.16M | 10.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.86M | 4.86M | 8.22M | 10.16M | 10.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.86M | 4.86M | 8.22M | 10.16M | 10.16M |
|
|
|||||